In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Elbion AG closes €35mm venture round

Executive Summary

Elbion AG (inflammation and CNS therapeutics) has completed its first venture round, bringing in €35mm ($44mm) for the company. 3i, Burrill & Co., and DVC Deutsche Venture Capital co-led the financing and were joined by AGF Private Equity, Quintiles PharmaBio Development, BayTech Venture Capital, Marubeni Corp., TVM Techno Venture Management, Temasek Holdings, and Mitsubishi Corp.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies